Exploring Cytotoxic mRNAs as a Novel Class of Anti-cancer Biotherapeutics

New treatments to overcome the obstacles of conventional anti-cancer therapy are a permanent subject of investigation. One promising approach is the application of toxins linked to cell-specific ligands, so-called immunotoxins. Another attractive option is the employment of toxin-encoding plasmids....

Descripción completa

Detalles Bibliográficos
Autores principales: Hirschberger, Kristin, Jarzebinska, Anita, Kessel, Eva, Kretzschmann, Verena, Aneja, Manish K., Dohmen, Christian, Herrmann-Janson, Annika, Wagner, Ernst, Plank, Christian, Rudolph, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908148/
https://www.ncbi.nlm.nih.gov/pubmed/29687033
http://dx.doi.org/10.1016/j.omtm.2017.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908148/
https://www.ncbi.nlm.nih.gov/pubmed/29687033
http://dx.doi.org/10.1016/j.omtm.2017.12.006

Ejemplares similares